{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "esgPopulated": false, "market": "au_market", "longName": "Race Oncology Limited", "marketState": "POSTPOST", "regularMarketPrice": 1.8, "messageBoardId": "finmb_337678960", "exchange": "ASX", "shortName": "RACEONCO FPO", "exchangeTimezoneShortName": "AEST", "exchangeTimezoneName": "Australia/Sydney", "regularMarketChangePercent": 0.0, "gmtOffSetMilliseconds": 36000000, "fiftyTwoWeekLowChange": 0.3499999, "fiftyTwoWeekLowChangePercent": 0.24137923, "fiftyTwoWeekRange": "1.45 - 2.87", "fiftyTwoWeekHighChange": -1.0699999, "fiftyTwoWeekHighChangePercent": -0.37282228, "fiftyTwoWeekLow": 1.45, "fiftyTwoWeekHigh": 2.87, "earningsTimestamp": 1682638855, "earningsTimestampStart": 1682638855, "earningsTimestampEnd": 1682638855, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "firstTradeDateMilliseconds": 1468368000000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683870847, "regularMarketDayHigh": 1.835, "regularMarketDayRange": "1.78 - 1.835", "regularMarketDayLow": 1.78, "regularMarketVolume": 27774, "regularMarketPreviousClose": 1.8, "bid": 1.79, "ask": 1.81, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 1.835, "averageDailyVolume3Month": 135785, "averageDailyVolume10Day": 83949, "sharesOutstanding": 161311008, "bookValue": 0.191, "fiftyDayAverage": 1.9383, "fiftyDayAverageChange": -0.13830006, "fiftyDayAverageChangePercent": -0.071351215, "twoHundredDayAverage": 2.05865, "twoHundredDayAverageChange": -0.25865006, "twoHundredDayAverageChangePercent": -0.12564062, "marketCap": 296812800, "priceToBook": 9.424084, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "symbol": "RAC.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Gateway, 1 Macquarie Place", "address2": "Level 36", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 8051 3043", "fax": "61 2 8051 3043", "website": "https://www.raceoncology.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Daniel  Tillett", "title": "Exec. Officer", "fiscalYear": 2022, "totalPay": {"raw": 375007, "fmt": "375.01k", "longFmt": "375,007"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Damian  Clarke-Bruce", "title": "MD, CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Christina  Manfre", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Tim  Hammond", "title": "Interim Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ajay  Duggal Dip Pharm Med, MB ChB, MRCP", "title": "Interim Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD", "age": 59, "title": "Company Sec.", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}